Literature DB >> 31525323

An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines.

Mehdi Mohebali1, Abolhassan Nadim2, Ali Khamesipour3.   

Abstract

Leishmanization (LZ) is an intradermal inoculation of live Leishmania to induce an artificial cutaneous leishmaniasis (CL) lesion in a covered part of the body to protect against further natural CL lesion development. Leishmanization has been used from ancient times and when NNN medium was developed continued with using Leishmania from culture media. The objective of this study was to review LZ published experiences. This article is a review of LZ experiences and historical studies initiated since 1910 when Leishmania promastigotes were harvested from culture media and used for LZ. This review includes LZ experiences in Israel, some countries of Former Soviet Union and Iran. The results of LZ in Israel, some countries of Former Soviet Union and Iran showed that despite limitations, using this method significantly reduced the incidence rate of CL among leishmanized individuals in endemic areas. In conclusion, leishmanization using Leishmania major produced under GMP guideline is a valuable tool to protect against CL, there are limitations which need further study.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cutaneous leishmanization; Human; Leishmanization

Mesh:

Substances:

Year:  2019        PMID: 31525323     DOI: 10.1016/j.actatropica.2019.105173

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  10 in total

1.  Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis.

Authors:  María José Germanó; Juan Pablo Mackern-Oberti; Jessica Gardone Vitório; Mariana Costa Duarte; Daniel Carvalho Pimenta; Maria Victoria Sanchez; Flavia Alejandra Bruna; Esteban Sebastián Lozano; Ana Paula Fernandes; Diego Esteban Cargnelutti
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Characterization of a new Leishmania major strain for use in a controlled human infection model.

Authors:  Helen Ashwin; Jovana Sadlova; Barbora Vojtkova; Tomas Becvar; Patrick Lypaczewski; Eli Schwartz; Elizabeth Greensted; Katrien Van Bocxlaer; Marion Pasin; Kai S Lipinski; Vivak Parkash; Greg Matlashewski; Alison M Layton; Charles J Lacey; Charles L Jaffe; Petr Volf; Paul M Kaye
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

Review 3.  Revival of Leishmanization and Leishmanin.

Authors:  Thalia Pacheco-Fernandez; Greta Volpedo; Sreenivas Gannavaram; Parna Bhattacharya; Ranadhir Dey; Abhay Satoskar; Greg Matlashewski; Hira L Nakhasi
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

4.  Experiences on Cutaneous Leishmaniasis Control in Imposed Iran-Iraq War 1980-1988.

Authors:  Ali Mehrabi Tavana
Journal:  Iran J Parasitol       Date:  2020 Oct-Dec       Impact factor: 1.012

Review 5.  Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

Authors:  Kwang Poo Chang; Joseph M Reynolds; Ying Liu; Johnny J He
Journal:  Vaccines (Basel)       Date:  2022-02-07

6.  The First Case of Basal Cell Carcinoma in the Scar Fifty Years after Leishmanization.

Authors:  Nelli Ignatievna Tumolskaya; Vladimir Petrovich Sergiev; Olga Petrovna Zelya; Valerij Dmitrievich Zavoikin
Journal:  Iran J Parasitol       Date:  2022 Jan-Mar       Impact factor: 1.217

7.  Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major.

Authors:  Akram Miramin-Mohammadi; Amir Javadi; Seyyed Ebrahim Eskandari; Mahmood Nateghi-Rostami; Ali Khamesipour
Journal:  J Arthropod Borne Dis       Date:  2021-03-31       Impact factor: 1.198

Review 8.  Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

Authors:  María Álvarez-Bardón; Yolanda Pérez-Pertejo; César Ordóñez; Daniel Sepúlveda-Crespo; Nestor M Carballeira; Babu L Tekwani; Sankaranarayanan Murugesan; Maria Martinez-Valladares; Carlos García-Estrada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2020-03-31       Impact factor: 5.118

9.  Vaccination in Leishmaniasis: A Review Article.

Authors:  Latifeh Abdellahi; Fariba Iraji; Anahita Mahmoudabadi; Seyed Hossein Hejazi
Journal:  Iran Biomed J       Date:  2022-01-01

10.  A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study).

Authors:  Vivak Parkash; Helen Ashwin; Jovana Sadlova; Barbora Vojtkova; Georgina Jones; Nina Martin; Elizabeth Greensted; Victoria Allgar; Shaden Kamhawi; Jesus G Valenzuela; Alison M Layton; Charles L Jaffe; Petr Volf; Paul M Kaye; Charles J N Lacey
Journal:  Wellcome Open Res       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.